Dr. Torres is a pioneer in microbiome-based therapeutics, leading the development of precision-engineered probiotics for autoimmune conditions.
156
Articles
11,890
Citations
48
h-index
21,400
Followers
Microbiome-Based Therapy Induces Remission in 67% of Autoimmune Patients
Precision-engineered probiotics show remarkable efficacy against rheumatoid arthritis.
Fecal Microbiota Transplant Shows Promise for Treatment-Resistant C. difficile
Standardized FMT protocol achieves 92% cure rate in recurrent C. difficile infections.
Education
MD
Columbia University · 2011
PhD Microbiology
Caltech · 2008
Fellowship
Cleveland Clinic · 2015
Quick Links
Dr. Torres is a pioneer in microbiome-based therapeutics, leading the development of precision-engineered probiotics for autoimmune conditions.
156
Articles
11,890
Citations
48
h-index
21,400
Followers
Microbiome-Based Therapy Induces Remission in 67% of Autoimmune Patients
Precision-engineered probiotics show remarkable efficacy against rheumatoid arthritis.
Fecal Microbiota Transplant Shows Promise for Treatment-Resistant C. difficile
Standardized FMT protocol achieves 92% cure rate in recurrent C. difficile infections.
Education
MD
Columbia University · 2011
PhD Microbiology
Caltech · 2008
Fellowship
Cleveland Clinic · 2015